Novartis Drug Helps Patients With Rare Inflammatory Diseases

Published November 11, 2012

Novartis drug helps patients with rare inflammatory diseases

Filed under: drug treatment programs washington dc

Both studies are being presented at the American College of Rheumatology (ACR) meeting in Washington D.C.. Ilaris or ACZ885, which blocks a protein called interleukin-1 beta that is thought to increase … Novartis is hoping to show the drug can be …
Read more on Reuters

Use of Xarelto Expanded to Treat Blood Clots

Filed under: drug treatment programs washington dc

Washington, D.C. – infoZine – The U.S. Food and Drug Administration expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following …
Read more on Kansas City infoZine

Malarial Drug Shows 'Hopeful' Promise in Preventing Breast Cancer

Filed under: drug treatment programs washington dc

Researchers at George Mason University, near Washington DC, are conducting a clinical trial to see if a widely-prescribed drug used to prevent and treat malaria, called chloroquine (pronounced klor' oh kwin), will do the same for ductal carcinoma in …
Read more on EmpowHer

AHA: HDL Boosters Still Promising

Filed under: drug treatment programs washington dc

LOS ANGELES – Researchers continue the development of drugs designed to increase production of the so-called good cholesterol – high density lipoprotein cholesterol (HDL), despite bad news on that front at the annual scientific sessions of the American …
Read more on MedPage Today